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Primitive neuroectodermal tumors (PNETs) in the genital
tract are very rarely encountered by gynecologists. They are a
member of the Ewing sarcoma family. Primitive neuro-
ectodermal tumors encompass a group of embryonic tumors
with varying degrees of neuronal differentiation. Peripheral
PNETs are small round blue cell tumors with a neuroectodermal
origin [1]. Most PNETs of the genital tract occur in the ovary, and
more rarely in the vulva, vagina, cervix, and uterus. The litera-
ture has only a few case reports and small case series on PNET of
the genital tract. In this correspondence, we report three rare
cases of PNET with genital tract origin that arose from the vulva,
uterus, and ovary, and we assess the clinical characteristics of
these neoplasms.
We have diagnosed three cases of PNET of the genital tract, the
clinical features of which are described in Table 1. The PNETs had a
wide range of age distribution and clinical presentation. The tu-
mors ranged in size from 4 cm to 35 cm.
Medical histories and imaging studies alone are inadequate
for a deﬁnitive diagnosis of PNET. Primitive neuroectodermal
tumors can be diagnosed via histological investigation of a
sample. It is characterized as small round cells with the forma-
tion of pseudo-rosettes and HomereWright rosettes [2].* Corresponding author. Gynecologic Oncology Department, Zekai Tahir Burak
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1028-4559/Copyright © 2015, Taiwan Association of Obstetrics & Gynecology. PublishedEndometrial stromal sarcoma, granulose cell tumors, carcinoid
tumor, rabdomyosarcoma, neuroblastoma, osteosarcoma, Wilms
tumor, and malignant melanoma should be considered in the
differential diagnosis Distinction between these tumors can be
very difﬁcult without additional studies such as histochemistry
and electron microscopy. An exact differential diagnosis can be
determined with the assistance of immunohistochemical studies.
The transmembrane protein CD99 is a very useful and sensitive
immune histochemical marker; however, other small round blue
cell tumors such as small cell carcinoma, rhabdomyosarcoma,
and lymphoma can also show immunoreactivity to CD99. For
most patients, routine histologic and immunohistochemical ex-
amination is sufﬁcient to render a correct diagnosis of PNET;
however, genetic analysis is very helpful when morphology is
inconclusive or when these tumors appear in an unusual clinical
setting.
There is no standard treatment regimen for peripheral PNET
because of the rare number of cases, which appear in different lo-
cations. Treatment for peripheral PNET has included complete
surgical excision of the lesion, chemotherapy, and, occasionally,
radiation therapy. Local surgery or radiotherapy alone has a high
risk of mortality and recurrence. Some authors have advocated 6
weeks of chemotherapy before and after surgery and radiotherapy
to increase disease-free survival rates [3]. Chemotherapy regimen
consisting of iphosphomide, doxorubicin, cyclophosphomide, eto-
poside and cysplatin can be used in the treatment. However, certain
protocols cannot be established for these rare cases because of their
sporadic nature.
After 18 months of follow up without any recurrences, we lost
contact with one of the three patients. The other two patients have
shown no signs of recurrences during their follow up. All three
patients did not indicate any serious complications with the sur-
gery or the chemotherapy regimen.
In summary, peripheral PNET in the pelvic region is a rare and
aggressive tumor with a high rate of recurrence. It clinically re-
sembles a benign condition. For patients with heterogeneous
large volume masses, PNET should be considered in the differ-
ential diagnosis. Advanced pathological investigation techniquesby Elsevier Taiwan LLC. All rights reserved.
Table 1
Clinical presentation, treatment, and follow up of primitive neuroectodermal tumors in the female genital tract.
Case
No.
Age
(y)
Disease
site
Clinical
presentation
Surgery Cd99 S100 Vimentin Nse Cd117 Additional therapy Follow up
1 42 Vulva Vulvar mass Bilateral radical
vulvectomy & femoral
lymph node dissection
þ chemotherapy
þ radiotherapy
(þ) (þ) (þ) () () Carboplatin þ adriamycin
þ external radiotherapy
18 mo disease-free
(last information in
Feb 2014)
2 51 Uterus Pelvic pain Mass excisions, left
hemicolectomy,
appendectomy,
& omentectomy
(þ) () (þ) (þ) () Etaposide & cycplatine 14 mo disease-free
(no signs of recurrence
at her last visit in
Jul 2014)
3 33 Ovary Abdominal
tenderness
Mass excision (þ) () (þ) () (þ) Adriamycin þ cisplatin
þ external radiotherapy
10 mo disease-free
(no signs of recurrence
at her last visit
in Jun 2014)
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treatment regimen can be developed by the presentation of cases
and their prognosis in the literature.Conﬂicts of interest
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